Market research
CRY GraniteShares YieldBOOST CRCL ETF
NASDAQ USD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 703M
- P/E ratio
- 425.71
- Analyst target
- 32.44
- Dividend yield
- 0.2%
- Beta
- 0.0
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- ISIN
- US2289031005
- Market cap
- 703M
- P/E ratio
- 425.71
- Analyst target
- 32.44
- Dividend yield
- 0.2%
- Beta
- 0.0
About
About GraniteShares YieldBOOST CRCL ETF
The fund will invest at least 80% of its net assets in derivatives contracts that utilize the Underlying Leveraged ETF as their reference asset. It is non-diversified.
Research context
GraniteShares YieldBOOST CRCL ETF appears in PyInvesting’s ETF catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the CRY discussion.
5 years, 6 months ago
CryoLife, Inc is currently in a long term uptrend where the price is trading 15.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.
CryoLife, Inc's total revenue sank by 2.6% to $68M since the same quarter in the previous year.
Its net income has dropped by 407.8% to $-3M since the same quarter in the previous year.
Finally, its free cash flow grew by 284.0% to $3M since the same quarter in the previous year.
Based on the above factors, CryoLife, Inc gets an overall score of 3/5.